Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • Standards of Medical Care
    • Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
  • Browse
    • By Topic
    • Issue Archive
    • Scientific Sessions Abstracts
  • Info
    • About the Journal
    • Meet the Editors
    • Reprints & Permissions
    • Journal Policies
    • For Authors
    • For Reviewers
    • For Advertisers
  • Subscriptions
    • Manage Online Access
    • Individual Subscriptions
    • Institutional Subscriptions
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Diabetes Discovery
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Journal Policies
    • Instructions for Authors
    • Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • Standards of Medical Care
    • Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
  • Browse
    • By Topic
    • Issue Archive
    • Scientific Sessions Abstracts
  • Info
    • About the Journal
    • Meet the Editors
    • Reprints & Permissions
    • Journal Policies
    • For Authors
    • For Reviewers
    • For Advertisers
  • Subscriptions
    • Manage Online Access
    • Individual Subscriptions
    • Institutional Subscriptions
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Diabetes Discovery
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Journal Policies
    • Instructions for Authors
    • Peer Review
Commentaries

Oxidative Stress and Obesity: The Chicken or the Egg?

  1. Annayya R. Aroor1,3,4 and
  2. Vincent G. DeMarco1,2,3,4⇑
  1. 1Department of Internal Medicine, University of Missouri School of Medicine, Columbia, MO
  2. 2Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, MO
  3. 3Diabetes and Cardiovascular Center, University of Missouri, Columbia, MO
  4. 4Harry S. Truman VA Medical Center, Columbia, MO
  1. Corresponding author: Vincent G. DeMarco, demarcov{at}missouri.edu.
Diabetes 2014 Jul; 63(7): 2216-2218. https://doi.org/10.2337/db14-0424
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Over the past 30 years much research has focused on elucidating mechanisms linked to progression of obesity and its cardiovascular comorbidities. As the central dogma regarding the pathophysiology of obesity unfolds, it is evident that the expansion of visceral adipose tissue caused by overconsumption of nutrients plays a central role. As visceral fat stores expand, adipocytes generate increasing levels of reactive oxygen species (ROS) that incite increased expression and secretion of inflammatory adipokines (1–3). Oxidative stress leads to insulin resistance within adipose tissue as well as in peripheral tissues. Insulin resistance is one of the hallmarks of obesity and accounts for many of its comorbidities, including hypertension (4).

Accumulation of oxidative stress in adipose tissue is one of the early events in the development of metabolic syndrome in obesity (5). On the other hand, weight loss by calorie restriction and/or exercise can ameliorate the state of oxidative stress (6). Nonetheless, a cause and effect relationship between oxidative stress and obesity is not well understood. NADPH oxidase is a major contributor to oxidative stress in many tissues, including adipose tissue and the vasculature (5,7,8). Conversely, factors causing oxidative stress, such as angiotensin II, that induce insulin resistance do not necessarily induce body weight gain (9). Therefore, whether oxidative stress, per se, leads to weight gain is an important gap in our understanding of the pathophysiology of obesity.

In this issue, Youn et al. (10) propose that oxidative stress contributes to obesity rather than the other way around, as has been the conventional thinking (a chicken-and-egg scenario). The most significant finding of their study is the first demonstration that ROS of vascular origin play an important causal role in the development of obesity. They hypothesize that ROS generated in vascular smooth muscle cells (VSMCs) by NADPH oxidase induce obesity. In this elegant study, they used both knock-in and knockout mouse models designed to enhance or abrogate NADPH oxidase–mediated oxidative stress. NADPH oxidase plays a major role in generating ROS in VSMCs (7,8). These multisubunit oxidases consist of one of the catalytic NOX proteins (NOX1 or NOX4 in the vasculature) and p22phox, the latter acting to stabilize NOX expression and serving as a docking station for the remaining cytoplasmic subunits of the oxidase complex (Fig. 1). To address their hypothesis, the authors used a transgenic mouse (tgsm/p22phox) model that overexpresses p22phox in VSMCs. In a previous report by this group, they validated specific p22phox overexpression in VSMCs and demonstrated concomitant increases in NOX1 expression and H2O2 generation (11). Despite the elevated level of oxidative stress, they detected no abnormalities in endothelium-dependent vasodilation in aortic explants nor did they observe increases in systolic blood pressure. They attributed the preservation of vascular function to a compensatory response that counters the deleterious effects of oxidative stress and is characterized by an H2O2-induced increase in the expression of endothelial nitric oxide synthase protein with subsequent generation of nitric oxide (NO), in concert with an increase in extracellular superoxide dismutase expression (Fig. 1).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Oxidative stress of vascular origin induces obesity. Panels A and B depict excessive superoxide generation by the NADPH oxidase complex in VSMCs of tgsm/p22phox mice under baseline conditions and the compensatory vascular and metabolic responses that contribute to preservation of vascular function as reported previously by the authors (11). WT mice fed a Western diet high in fat for several months exhibit a number of abnormalities typically observed in metabolic syndrome (C). The consequences of feeding tgsm/p22phox mice an HFD for 6 weeks are similar to those observed with long-term HFD feeding (D). ecSOD, extracellular superoxide dismutase; eNOS, endothelial nitric oxide synthase; KO, knockout; PVAT, perivascular fat; RAAS, renin-angiotensin-aldosterone system.

Youn et al. (10) report that 6-month-old tgsm/p22phox mice fed a high-fat diet (HFD) for 6 weeks developed markedly exaggerated obesity compared with HFD-fed wild-type (WT) mice. Specifically, HFD-fed tgsm/p22phox mice gained 50% more weight than their WT counterparts. HFD feeding also augmented body fat accumulation, leptin levels, and glucose intolerance in tgsm/p22phox mice, components of the metabolic syndrome, compared with WT mice (Fig. 1). Importantly, weight gain was not due to increased calories consumed by the tgsm/p22phox mice. It should be noted that given a sufficiently long exposure to an HFD, say 4–6 months depending on the diet formulation, WT mice develop metabolic syndrome (Fig. 1). Thus, tgsm/p22phox mice exhibit a relatively rapid induction of obesity, which the authors ascribe to the early and marked increase in leptin levels that are likely induced by the combination of elevated vascular ROS and an HFD environment. The authors also suggest the possibility that ROS of vascular origin diffuse into nearby skeletal muscle cells, inciting a feed-forward scenario to induce mitochondrial ROS formation (ROS-induced ROS). As such, vascular ROS may induce skeletal muscle dysfunction, leading to reduced activity and energy expenditure that would promote obesity. Their results were further supported by studies on knockout mice that are deficient in vascular ROS production (p22phoxloxp/loxp/tgsmmhc/cre mice). In these mice, HFD feeding did not induce weight gain or leptin resistance. Moreover, knockout mice fed an HFD exhibited decreased T-cell infiltration into perivascular fat, suggesting that vascular ROS could incite an inflammatory response that contributes to the development of obesity.

The idea that ROS of vascular origin are a cause rather than a consequence of obesity is very appealing, nonetheless several questions remain unanswered. First, in Fig. 3 of their article, it is evident that 6-month-old tgsm/p22phox mice are approximately 15–20% heavier than WT mice under baseline conditions. Despite being overweight, tgsm/p22phox mice do not exhibit the suite of abnormalities observed in HFD-fed tgsm/p22phox mice (Fig. 1). Perhaps this could be interpreted as evidence that vascular ROS by itself promotes a condition of overweight independent of hyperleptinemia, glucose intolerance, and inflammation. Second, the authors did not address whether the adaptive mechanisms related to NO signaling (Fig. 1A) encountered in tgsm/p22phox mice fed a normal diet (11) are abrogated in HFD-fed mice. In this regard, it might be predicted that there will be a loss of vasoprotection in concert with augmented obesity and a dysregulated inflammatory response, and this would eventually lead to vascular dysfunction and hypertension. These issues may help to answer the role of NO and immune function in oxidative stress–mediated vascular dysfunction, as these mice are targeted for vascular-mediated oxidative stress. Third, it would also be interesting to know whether oxidative stress–mediated responses to factors contributing to hyperleptinemia, insulin resistance, reduced activity, and inflammation, such as renin-angiotensin-aldosterone system activation, could also be potentiated in tgsm/p22phox mice. It is hoped that future extensions of the study by Youn et al. (10) will provide further mechanistic insight into the pathophysiology of obesity and the role of vascular oxidative stress in mediating vascular dysfunction in obesity.

Article Information

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Footnotes

  • See accompanying article, p. 2344.

  • © 2014 by the American Diabetes Association.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

References

  1. ↵
    1. Otani H
    . Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid Redox Signal 2011;15:1911–1926pmid:21126197
    OpenUrlCrossRefPubMed
    1. DeMarco VG,
    2. Johnson MS,
    3. Whaley-Connell AT,
    4. Sowers JR
    . Cytokine abnormalities in the etiology of the cardiometabolic syndrome. Curr Hypertens Rep 2010;12:93–98pmid:20424939
    OpenUrlCrossRefPubMed
  2. ↵
    1. Keaney JF Jr.,
    2. Larson MG,
    3. Vasan RS,
    4. et al.,
    5. Framingham Study
    . Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003;23:434–439pmid:12615693
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Sowers JR,
    2. Whaley-Connell A,
    3. Hayden MR
    . The role of overweight and obesity in the cardiorenal syndrome. Cardiorenal Med 2011;1:5–12pmid:22258461
    OpenUrlCrossRefPubMed
  4. ↵
    1. Furukawa S,
    2. Fujita T,
    3. Shimabukuro M,
    4. et al
    . Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752–1761pmid:15599400
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Imayama I,
    2. Ulrich CM,
    3. Alfano CM,
    4. et al
    . Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res 2012;72:2314–2326pmid:22549948
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Griendling KK,
    2. Sorescu D,
    3. Ushio-Fukai M
    . NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000;86:494–501pmid:10720409
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Cai H,
    2. Griendling KK,
    3. Harrison DG
    . The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 2003;24:471–478pmid:12967772
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Blendea MC,
    2. Jacobs D,
    3. Stump CS,
    4. et al
    . Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression. Am J Physiol Endocrinol Metab 2005;288:E353–E359pmid:15494608
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Youn J-Y,
    2. Siu KL,
    3. Lob HE,
    4. Itani H,
    5. Harrison DG,
    6. Cai H
    . Role of vascular oxidative stress in obesity and metabolic syndrome. Diabetes 2014;63:2344–2355pmid:24550188
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Laude K,
    2. Cai H,
    3. Fink B,
    4. et al
    . Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice. Am J Physiol Heart Circ Physiol 2005;288:H7–H12pmid:15471976
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Diabetes: 63 (7)

In this Issue

July 2014, 63(7)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Oxidative Stress and Obesity: The Chicken or the Egg?
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
Citation Tools
Oxidative Stress and Obesity: The Chicken or the Egg?
Annayya R. Aroor, Vincent G. DeMarco
Diabetes Jul 2014, 63 (7) 2216-2218; DOI: 10.2337/db14-0424

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Oxidative Stress and Obesity: The Chicken or the Egg?
Annayya R. Aroor, Vincent G. DeMarco
Diabetes Jul 2014, 63 (7) 2216-2218; DOI: 10.2337/db14-0424
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • SRGAP2a: A New Player That Modulates Podocyte Cytoskeleton and Injury in Diabetes
  • Values and Limitations of Targeting lncRNAs in Diabetic Nephropathy
  • A Weighty Matter: Can PUFAs in Pregnancy Prevent Obesity?
Show more Commentaries

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • For Advertisers
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Scientific Sessions Abstracts
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2018 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.